• Disease areas
  • Products
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Media & Investors
  • Contact us

Ozempic<sup>®</sup> (semaglutide) injection

Ozempic<sup>®</sup> (semaglutide) tablets

Rybelsus<sup>®</sup> (semaglutide) tablets

Victoza<sup>®</sup> (liraglutide) injection

Awiqli<sup>®</sup> (insulin icodec-abae) injection

Fiasp<sup>®</sup> (insulin aspart) injection

Novolin<sup>®</sup> 70/30 (70% human insulin isophane suspension and 30% human insulin) injection

Novolin<sup>®</sup> N (isophane insulin human) suspension

Novolin<sup>®</sup> R (insulin human) injection

NovoLog<sup>®</sup> (insulin aspart) injection

NovoLog<sup>®</sup> Mix 70/30 (insulin aspart protamine and insulin aspart) injectable suspension

Tresiba<sup>®</sup> (insulin degludec) injection

Xultophy<sup>®</sup> 100/3.6 (insulin degludec and liraglutide) injection

Zegalogue<sup>®</sup> (dasiglucagon) injection

Blood glucose monitoring

© 2026 Novo Nordisk All rights reserved. US26DI00008 June 2026

NOVO NORDISK USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

  • Contact us
  • Copyright
  • Report a side effect or product complaint

Follow us

  • Facebook
  • X (Twitter)
  • Instagram

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Notice
Cookie Settings
Your Privacy Choices

change